8
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Percutaneous coronary intervention with adjunctive abciximab and clopidogrel in a patient with chronic idiopathic thrombocytopaenic purpura

Pages 35-38 | Published online: 10 Jul 2009

  • Mathew TC, Vasudevan R, Leb L et al. Coronary artery bypass grafting in immune thrombocytopenic purpura. Ann ThoracSurg 1997; 64: 1059-1062.
  • Fuchi T, Kondo T, Sase K et al. Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. Jpn Circ J 1999; 63: 133-136.
  • Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRlSC 11 invasive randomised trial. FRlSC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Eancet 2000; 356: 9-16.
  • Eandl JH. Blood-Textbook of Haematology. 2nd ed. Boston, MA Little, Brown and Co, 1996: 1311.
  • The EPlSTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronaiy stenting with use of platelet glycoprotein- lib/Ilia blockade. Evaluation of Platelet lib/Ilia Inhibitor for Stenting. Lancet 1998; 352: 87-92.
  • Muller C, Buttner HJ, Petersen J et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000; 101: 590-593.
  • Bennett CL, Connors JM, Carwile JM et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000; 342: 1773-1777.
  • Jordan RE, Wagner CL, Mascaill MA et al. Preclinical development of c7E3 Fab; a mouse/human chimeric monoclonal antibody fragment that inhibits platelet function by blockade of GPllb/Illa receptors with observations on the immunogenicity of c7E3 Fab in humans. In: Horton MA, ed. Adhesion Receptors as Therapeutic Targets. Boca Raton, Fl CRC Press, 1996:281-302.
  • Casterella Kereiakes DJ, Steinhubl SR et al. J Am Coll Cardiol 1999;33(Suppl A): 39A. Use of rapid platelet function analysis (RPFA) to evaluate platelet function in patients receiving incremental bolus dosing of abciximab during percutaneous coronaiy intervention (PCl).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.